Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments
The AI Nurse Companion, designed as a language-first learning platform, allows students to gain real-world German language proficiency through immersive practice
The initiative is being led through the Bank’s CSR programme, Parivartan, in partnership with the Indian Cancer Society
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
Experts caution that realizing AI’s potential requires careful management and risk mitigation
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
The partnership will launch a Phase 1b cohort within Boehringer’s ongoing Beamion-BCGC1 trial
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
Subscribe To Our Newsletter & Stay Updated
